LTR PHARMA LIMITED ORDINARY (LTP) Short Interest

Name: LTR PHARMA LIMITED ORDINARY (LTP) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

LTR PHARMA LIMITED ORDINARY (ASX:LTP) had 0.26% of shares reported as short positions as of 4 June 2026, representing 475,090 shares. LTR PHARMA LIMITED ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.26%
Reported positions: 475,090
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 4 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

LTP

Ltr Pharma

Pharmaceuticals, Biotechnology & Life Sciences

LTR Pharma is an Australian drug development company focused on men's health, specifically commercializing a rapid-onset, on-demand therapeutic nasal spray for erectile dysfunction. Their lead product, SPONTAN®, utilizes intranasal delivery technology of a PDE5 inhibitor, aiming for faster action and improved spontaneity compared to existing ED therapies.

pharmaceuticals

biotechnology

men's health

erectile dysfunction

Shorted

short percentage0.26%

reported shorts475.1K

shares on issue181.778M